Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Tachezy, Ruth ^a   Smahelova, Jana ^a   Salakova, Martina ^a   Arbyn, Marc ^b   Rob, Lukas ^c   Skapa, Petr ^c   Jirasek, Tomas ^c   Hamsikova, Eva ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; GENITAL SYSTEM DISEASE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 55; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 71; HUMAN PAPILLOMAVIRUS TYPE 81; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN PAPILLOMAVIRUS TYPE 89; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRECANCER; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS TYPING; WART VIRUS; ADOLESCENT; ANUS TUMOR; GENETICS; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PREVALENCE; VIROLOGY; VULVA TUMOR;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDYLOMATA ACUMINATA; CZECH REPUBLIC; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREVALENCE; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 79960213803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021913     Document Type: Article

References (46)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
2. zur Hausen H, Gissmann L, Steiner W, Dippold W, Dreger I, (1975) Human papilloma viruses and cancer. Bibl Haematol pp. 569-571.
3. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, et al. (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365-1371.
4. Gillison ML, Shah KV, (2003) Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr pp. 57-65.
5. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, et al. (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7: 453-459.
6. Clifford GM, Smith JS, Aguado T, Franceschi S, (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89: 101-105.
7. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, et al. (2005) Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14: 1157-1164.
8. Kreimer AR, Clifford GM, Boyle P, Franceschi S, (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475.
9. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, et al. (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121: 621-632.
10. Hoots BE, Palefsky JM, Pimenta JM, Smith JS, (2009) Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 124: 2375-2383.
11. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM, (2009) Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 113: 917-924.
12. De VH, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S, (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124: 1626-1636.
13. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S, (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63-73.
14. Parkin DM, Bray F, (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24 (Suppl 3): S3-11-S3/25.
15. Cancer incidence 2007 in the Czech Republic (2010) UZIS CR, NOR CR.
16. Arbyn M, Autier P, Ferlay J, Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 2007 18: 1423-5.
17. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, et al. (2008) Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44: 557-564.
18. Kornya L, Cseh I, Deak J, Bak M, Fulop V, (2002) The diagnostics and prevalence of genital human papillomavirus (HPV) infection in Hungary. Eur J Obstet Gynecol Reprod Biol 100: 231-236.
19. Kulmala SM, Shabalova IP, Petrovitchev N, Syrjanen KJ, Gyllensten UB, et al. (2007) Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union. J Med Virol 79: 771-781.
20. Speich N, Schmitt C, Bollmann R, Bollmann M, (2004) Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol 53: 125-128.
21. Tachezy R, Hamsikova E, Hajek T, Mikyskova I, Smahel M, et al. (1999) Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol 58: 378-386.
22. Tachezy R, Mikyskova I, Ludvikova V, Rob L, Kucera T, et al. (2006) Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies. Eur J Clin Microbiol Infect Dis 25: 492-500.
23. Skapa P, Zamecnik J, Hamsikova E, Salakova M, Smahelova J, et al. (2007) Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination. Am J Surg Pathol 31: 1834-1843.
24. Tachezy R, Jirasek T, Salakova M, Ludvikova V, Kubecova M, et al. (2007) Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. APMIS 115: 195-203.
25. Arbyn M, Van Veen EB, Andersson K, Bogers J, Boulet G, et al. (2010) Cervical cytology biobanking in Europe. Int J Biol Markers 25: 117-125.
26. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, et al. (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40: 779-787.
27. IARC Monograph Working Group (2007) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon IARC.
28. Bernard HU, Burk RD, Chen Z, Van DK, Hausen H, et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
29. Munoz N, Bosch FX, de SS, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
30. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, et al. (1985) Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350-1354.
31. Eklund C, Zhou T, Dillner J, (2010) Global proficiency study of human papillomavirus genotyping. J Clin Microbiol 48: 4147-4155.
32. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, et al. (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125: 2151-2158.
33. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, et al. (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374: 301-314.
34. Jenkins D, (2008) A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecol Oncol 110: S18-S25.
35. Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, et al. (2009) The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis 199: 926-935.
36. Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, et al. (2009) The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis 199: 936-944.
37. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, et al. (2010) European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol 21: 448-458.
38. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, et al. (2004) PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 30: 302-308.
39. Szostek S, Klimek M, Zawilinska B, Kosz-Vnenchak M, (2008) Genotype-specific human papillomavirus detection in cervical smears. Acta Biochim Pol 55: 687-692.
40. Shipitsyna E, Zolotoverkhaya E, Kuevda D, Nasonova V, Romanyuk T, et al. (2011) Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia. Cancer Epidemiol 35: 160-164.
41. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11: 1048-1056.
42. Sabol I, Salakova M, Smahelova J, Pawlita M, Schmitt M, et al. (2008) Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J Clin Microbiol 46: 1606-1613.
43. Kowalewska M, Szkoda MT, Radziszewski J, Ptaszynski K, Bidzinski M, et al. (2010) The frequency of human papillomavirus infection in polish patients with vulvar squamous cell carcinoma. Int J Gynecol Cancer 20: 434-437.
44. Garland SM, Insinga RP, Sings HL, Haupt RM, Joura EA, (2009) Human papillomavirus infections and vulvar disease development. Cancer Epidemiol Biomarkers Prev 18: 1777-1784.
45. Munoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, et al. (2010) Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 102: 325-339.
46. Munoz N, Bosch FX, Castellsague X, Diaz M, de SS, et al. (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111: 278-285.